Cite
HARVARD Citation
Grobusch, M. et al. (2017). Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine. Lancet. 389 (10069), pp. 578-580. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grobusch, M. et al. (2017). Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine. Lancet. 389 (10069), pp. 578-580. [Online].